Home › Funds › SCS Capital Management LLC › ALNY

SCS Capital Management LLC position in ALNY

ALNYLAM PHARMACEUTICALS INC · Health Care

SCS Capital Management LLC reported holding 115,549 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$34.8M, representing 0.33% of its reported portfolio and ranking #47 among its reported holdings. SCS Capital Management LLC has disclosed ALNY holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)115.55K sh
Reported value held$34.78M
Portfolio Weight0.33%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SCS Capital Management LLC's ALNY position evolved

SCS Capital Management LLC first disclosed a stake in ALNY in Q1 2025 at 171,077 shares (US$46.2M). The position peaked in Q3 2025 at 150,668 shares, worth US$68.7M. Across 6 filings, SCS Capital Management LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 115,549 shares valued at US$34.8M — a reduction of -33,998 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 171.08K $46.19M New
Q2 2025 170.66K $55.65M Hold
Q3 2025 150.67K $68.70M Reduce
Q4 2025 149.61K $59.49M Reduce
Q1 2026 149.55K $49.48M Hold
Q2 2026 115.55K $34.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALNY and 13F data

ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALNY

All ALNY fund holders →

FAQ

How long has SCS Capital Management LLC held ALNY?

SCS Capital Management LLC has disclosed ALNY holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is SCS Capital Management LLC's current position in ALNY?

As of Q2 2026, SCS Capital Management LLC holds 115.55K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $34.78M, representing 0.33% of its reported portfolio and ranking #47.

Has SCS Capital Management LLC been buying or selling ALNY?

In the latest 13F filing (Q2 2026), SCS Capital Management LLC reduced its position in ALNY. The position peaked in Q3 2025 at 150.67K shares.

Which other funds hold ALNY?

Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.